Drug Shortage Report for TEVA-BROMAZEPAM
Report ID | 107952 |
Drug Identification Number | 02230585 |
Brand name | TEVA-BROMAZEPAM |
Common or Proper name | BROMAZEPAM 6MG TAB |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | BROMAZEPAM |
Strength(s) | 6MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 500 |
ATC code | N05BA |
ATC description | ANXIOLYTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-03-05 |
Estimated end date | 2020-03-31 |
Actual end date | 2020-03-11 |
Shortage status | Resolved |
Updated date | 2020-03-12 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-03-06 | English | Compare |
v2 | 2020-03-06 | French | Compare |
v3 | 2020-03-12 | English | Compare |
v4 | 2020-03-12 | French | Compare |
v5 | 2020-03-12 | English | Compare |
v6 | 2020-03-12 | French | Compare |
Showing 1 to 6 of 6